AGPAT5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.111600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.727600E-01
Normal-vs-Stage2
9.658800E-01
Normal-vs-Stage3
5.407600E-01
Normal-vs-Stage4
6.376800E-01
Stage1-vs-Stage2
8.210600E-01
Stage1-vs-Stage3
4.708400E-01
Stage1-vs-Stage4
8.162800E-01
Stage2-vs-Stage3
4.544200E-01
Stage2-vs-Stage4
6.280000E-01
Stage3-vs-Stage4
2.381000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.010200E-01
Normal-vs-AfricanAmerican
7.432400E-01
Normal-vs-Asian
6.580000E-01
Caucasian-vs-AfricanAmerican
7.312800E-01
Caucasian-vs-Asian
3.153800E-01
AfricanAmerican-vs-Asian
3.185800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.363000E-01
Normal-vs-Female
8.722200E-01
Male-vs-Female
7.753800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.194600E-01
Normal-vs-Age(41-60Yrs)
7.579600E-01
Normal-vs-Age(61-80Yrs)
9.237200E-01
Normal-vs-Age(81-100Yrs)
9.647200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.128400E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.662000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.815760E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.373200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.071600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.998200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.670600E-01
Normal-vs-Daily Drinker
3.444200E-01
Normal-vs-Weekly Drinker
8.173200E-01
Normal-vs-Occasional Drinker
4.857800E-01
Normal-vs-Social Drinker
8.503200E-01
Non Drinker-vs-Daily Drinker
1.834430E-01
Non Drinker-vs-Weekly Drinker
5.070800E-01
Non Drinker-vs-Occasional Drinker
9.593900E-02
Non Drinker-vs-Social Drinker
4.950800E-01
Daily Drinker-vs-Weekly Drinker
2.091200E-01
Daily Drinker-vs-Occasional Drinker
2.495400E-03
Daily Drinker-vs-Social Drinker
5.542300E-02
Weekly Drinker-vs-Occasional Drinker
8.493600E-01
Weekly Drinker-vs-Social Drinker
7.849600E-01
Occasional Drinker-vs-Social Drinker
4.089200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.909000E-01
Normal-vs-Grade 2
3.206800E-01
Normal-vs-Grade 3
3.266400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.103200E-01
Grade 1-vs-Grade 3
5.214200E-01
Grade 1-vs-Grade 4
4.909000E-01
Grade 2-vs-Grade 3
7.584600E-01
Grade 2-vs-Grade 4
3.206800E-01
Grade 3-vs-Grade 4
3.266400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.976000E-01
Normal-vs-NonDiabetic
9.558000E-01
Diabetic-vs-NonDiabetic
8.606400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.872970E-01
Normal-vs-NoPancreatitis
8.921600E-01
Pancreatitis-vs-NoPancreatitis
3.444000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.337400E-01
Normal-vs-N1
9.859000E-01
N0-vs-N1
1.970030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.566000E-01
Normal-vs-TP53-NonMutant
7.319200E-01
TP53-Mutant-vs-TP53-NonMutant
9.404400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
